FFPNX | OGLIX | FFPNX / OGLIX | |
Total Expense Ratio | 0.51 | 0.72 | 71% |
Annual Report Gross Expense Ratio | 0.51 | 0.72 | 71% |
Fund Existence | 5 years | 14 years | - |
Gain YTD | 15.938 | 9.306 | 171% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 159B | 9.2B | 1,729% |
Annual Yield % from dividends | 0.68 | 0.00 | - |
Returns for 1 year | 15.42 | 2.08 | 741% |
Returns for 3 years | 50.98 | 21.41 | 238% |
Returns for 5 years | N/A | 0.04 | - |
Returns for 10 years | N/A | 38.63 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 39.24 | 0.50 | +1.29% |
Eventide Healthcare & Life Sciences A | |||
RGACX | 83.16 | 0.19 | +0.23% |
American Funds Growth Fund of Amer R3 | |||
MECDX | 16.09 | 0.02 | +0.12% |
NYLI Epoch Capital Growth Class A | |||
FRAAX | 60.81 | N/A | N/A |
Franklin Growth Opportunities Adv | |||
DNLCX | 54.49 | -0.01 | -0.02% |
BNY Mellon Active MidCap C |